BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saavedra MÁ, Sánchez A, Morales S, Ángeles U, Jara LJ. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome. Clin Rheumatol 2015;34:1211-6. [DOI: 10.1007/s10067-015-2987-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol 2018;14:489-98. [PMID: 29764231 DOI: 10.1080/1744666X.2018.1476139] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken) 2020;72:461-88. [PMID: 32090466 DOI: 10.1002/acr.24130] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
3 Bray ER, Bray FN, Herskovitz I, Cho-Vega JH. New onset bullae in a pregnant woman. Int J Dermatol 2020;59:175-7. [PMID: 31183854 DOI: 10.1111/ijd.14513] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ponticelli C, Moroni G. Fetal Toxicity of Immunosuppressive Drugs in Pregnancy. J Clin Med 2018;7:E552. [PMID: 30558290 DOI: 10.3390/jcm7120552] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
5 Wu J, Ma J, Bao C, Di W, Zhang WH. Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. BMJ Open 2018;8:e020909. [PMID: 29654043 DOI: 10.1136/bmjopen-2017-020909] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
6 Saavedra MÁ, Miranda-hernández D, Sánchez A, Morales S, Cruz-domínguez P, Medina G, Jara LJ. Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study. Rheumatol Int 2016;36:1431-7. [DOI: 10.1007/s00296-016-3525-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
7 Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun 2018;93:16-23. [PMID: 30056945 DOI: 10.1016/j.jaut.2018.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
8 Götestam Skorpen C, Lydersen S, Gilboe I, Skomsvoll JF, Salvesen KÅ, Palm Ø, Koksvik HSS, Jakobsen B, Wallenius M. Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus. Arthritis Care & Research 2017;69:1201-8. [DOI: 10.1002/acr.23102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Presto JK, Werth VP. Cutaneous Lupus Erythematosus: Current Treatment Options. Curr Treat Options in Rheum 2016;2:36-48. [DOI: 10.1007/s40674-016-0033-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Blake SC, Daniel BS. Cutaneous lupus erythematosus: A review of the literature. Int J Womens Dermatol 2019;5:320-9. [PMID: 31909151 DOI: 10.1016/j.ijwd.2019.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
11 Chang Y, Shu Y, Sun X, Xu C, He D, Fang L, Chen C, Hu X, Kermode A, Qiu W. Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 2018;19:70-2. [PMID: 29149698 DOI: 10.1016/j.msard.2017.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Gordon C, Amissah-arthur M, Gayed M, Brown S, Bruce IN, D’cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; for the British Society for Rheumatology Standards, Audit and Guidelines Working Group. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 2018;57:e1-e45. [DOI: 10.1093/rheumatology/kex286] [Cited by in Crossref: 117] [Cited by in F6Publishing: 92] [Article Influence: 23.4] [Reference Citation Analysis]
13 Krain RL, Chen KL, Werth VP. Management of autoimmune blistering diseases in pregnancy and the neonate. G Ital Dermatol Venereol 2019;154:539-49. [PMID: 31195784 DOI: 10.23736/S0392-0488.19.06375-2] [Reference Citation Analysis]
14 Ingolotti M, Schlaen BA, Roig Melo-Granados EA, Ruiz García H, Aguilera Partida JA. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study. Am J Case Rep 2019;20:300-5. [PMID: 30842390 DOI: 10.12659/AJCR.914281] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher‐stine L, Crow‐hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72:529-56. [DOI: 10.1002/art.41191] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 39.0] [Reference Citation Analysis]
16 Belizna C, Meroni PL, Shoenfeld Y, Devreese K, Alijotas-Reig J, Esteve-Valverde E, Chighizola C, Pregnolato F, Cohen H, Fassot C, Mattera PM, Peretti P, Levy A, Bernard L, Saiet M, Lagarce L, Briet M, Rivière M, Pellier I, Gascoin G, Rakotonjanahary J, Borghi MO, Stojanovich L, Djokovic A, Stanisavljevic N, Bromley R, Elefant-Amoura E, Bahi Buisson N, Pindi Sala T, Kelchtermans H, Makatsariya A, Bidsatze V, Khizroeva J, Latino JO, Udry S, Henrion D, Loufrani L, Guihot AL, Muchardt C, Hasan M, Ungeheuer MN, Voswinkel J, Damian L, Pabinger I, Gebhart J, Lopez Pedrera R, Cohen Tervaert JW, Tincani A, Andreoli L. In utero exposure to Azathioprine in autoimmune disease. Where do we stand? Autoimmun Rev 2020;19:102525. [PMID: 32240856 DOI: 10.1016/j.autrev.2020.102525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
17 Dos Santos FC, Ignacchiti ML, Rodrigues B, Velarde LG, Levy RA, de Jesús GR, de Jesús NR, de Andrade CAF, Klumb EM. Premature rupture of membranes - A cause of foetal complications among lupus: A cohort study, systematic review and meta-analysis. Lupus 2021;30:2042-53. [PMID: 34806483 DOI: 10.1177/09612033211045056] [Reference Citation Analysis]
18 Baucom AM, Kuller JA, Dotters-Katz S. Immune Thrombocytopenic Purpura in Pregnancy. Obstet Gynecol Surv 2019;74:490-6. [PMID: 31418451 DOI: 10.1097/OGX.0000000000000697] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 de Groot EL, van Huet RAC, Bloemenkamp KWM, de Boer JH, Ossewaarde-van Norel J. Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy. Acta Ophthalmol 2021. [PMID: 34009733 DOI: 10.1111/aos.14898] [Reference Citation Analysis]
20 Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clinics in Dermatology 2016;34:344-52. [DOI: 10.1016/j.clindermatol.2016.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
21 Hiramatsu Y, Yoshida S, Kotani T, Nakamura E, Kimura Y, Fujita D, Nagayasu Y, Shabana K, Makino S, Takeuchi T, Arawaka S. Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus. Lupus 2018;27:2245-52. [PMID: 30394835 DOI: 10.1177/0961203318809178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
22 Kushner CJ, Concha JSS, Werth VP. Treatment of Autoimmune Bullous Disorders in Pregnancy. Am J Clin Dermatol 2018;19:391-403. [DOI: 10.1007/s40257-018-0342-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
23 Felten R, Scher F, Sibilia J, Chasset F, Arnaud L. Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond. Joint Bone Spine 2019;86:429-36. [PMID: 30243784 DOI: 10.1016/j.jbspin.2018.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Birru Talabi M, Clowse MEB. Antirheumatic medications in pregnancy and breastfeeding. Curr Opin Rheumatol. 2020;32:238-246. [PMID: 32205567 DOI: 10.1097/bor.0000000000000710] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
25 Jara LJ, Cruz-Dominguez MDP, Saavedra MA. Impact of infections in autoimmune rheumatic diseases and pregnancy. Curr Opin Rheumatol 2019;31:546-52. [PMID: 31169546 DOI: 10.1097/BOR.0000000000000636] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]